Latest Security News

Butn Limited has reported record revenue growth and its first positive operating cash flow for FY25, alongside securing a substantial $100 million funding facility to fuel future expansion.

Abacus Group has reversed last year’s losses to post a $26.9 million statutory profit in FY25, maintaining its distribution and signalling confidence for FY26 despite market challenges. The group’s commercial portfolio shows resilience, supported by a strategic stake in Abacus Storage King and ongoing capital management.

Abacus Group delivered a strong FY25 result with a significant profit increase and steady distributions, underpinned by resilient office and retail portfolios and a strategic focus on capital partnering.

Platinum Asia Investments Limited has finalized its special dividend payment, confirming an amount of AUD 0.2011 per share with a high franking percentage. The dividend is set for payment in September following court approval of its scheme of arrangement.

Abacus Group (ASX – ABG) reported a strong turnaround in FY25 with a net profit of $26.9 million and a 35.6% rise in revenue, maintaining steady distributions while navigating a strategic stake in Abacus Storage King amid an acquisition proposal.

MRG Metals Limited has seen its MRQOD securities suspended from ASX trading pending regulatory compliance, raising questions about the company’s next steps.

American West Metals has completed critical development and permitting milestones at its Storm Copper Project in Nunavut, Canada, advancing its Pre-Feasibility Study and revealing promising drilling results that hint at resource expansion.

Renascor Resources has completed key preparatory milestones for its Purified Spherical Graphite demonstration plant in Adelaide, with construction set to begin next month. The facility aims to challenge China’s dominance in battery anode materials using an innovative, eco-friendly purification process.

Noxopharm has successfully completed the third dosing phase of its HERACLES trial for SOF-SKN™, confirming safety and moving forward to the highest dose cohort in this pioneering autoimmune drug study.

An independent in vivo study from the University of South Florida reveals ArtemiC™ significantly boosts survival and reduces inflammation in a severe viral model, reinforcing its promise as a novel immunomodulatory therapy.

Alligator Energy has secured final regulatory approval to begin its in-situ Field Recovery Trial at the Samphire Uranium Project, advancing the development of its recently upgraded Blackbush Deposit resource.

Regal Partners reports a 48% drop in statutory profit for H1 2025 despite growing funds under management to $17.7 billion, while strategically expanding into hotel real estate with the Mayfair Hotel acquisition.